Opaleye Management as of Sept. 30, 2016
Portfolio Holdings for Opaleye Management
Opaleye Management holds 44 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Blueprint Medicines (BPMC) | 12.2 | $23M | 785k | 29.70 | |
Axogen (AXGN) | 9.4 | $18M | 2.0M | 9.03 | |
Ariad Pharmaceuticals | 7.5 | $14M | 1.0M | 13.69 | |
Medgenics | 5.2 | $10M | 1.8M | 5.57 | |
Agios Pharmaceuticals (AGIO) | 3.6 | $6.9M | 130k | 52.82 | |
Fibrogen (FGEN) | 3.6 | $6.8M | 330k | 20.70 | |
Foamix Pharmaceuticals | 3.0 | $5.8M | 630k | 9.26 | |
Cara Therapeutics (CARA) | 3.0 | $5.6M | 675k | 8.35 | |
Codexis (CDXS) | 2.7 | $5.2M | 1.2M | 4.44 | |
Cynapsus Therapeutics | 2.6 | $5.0M | 125k | 40.23 | |
Horizon Pharma | 2.6 | $5.0M | 275k | 18.13 | |
Eagle Pharmaceuticals (EGRX) | 2.6 | $4.9M | 70k | 70.00 | |
Imprimis Pharmaceuticals | 2.4 | $4.6M | 1.2M | 3.81 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 2.4 | $4.6M | 8.1M | 0.57 | |
Global Blood Therapeutics In | 2.4 | $4.6M | 200k | 23.05 | |
Macrogenics (MGNX) | 2.3 | $4.3M | 145k | 29.91 | |
Chimerix (CMRX) | 2.3 | $4.3M | 780k | 5.54 | |
Aquinox Pharmaceuticals | 2.2 | $4.1M | 310k | 13.36 | |
Adamas Pharmaceuticals | 2.1 | $4.1M | 250k | 16.41 | |
Immunomedics | 2.0 | $3.9M | 1.2M | 3.25 | |
Inotek Pharmaceuticals Corp conv | 2.0 | $3.8M | 400k | 9.48 | |
Xenon Pharmaceuticals (XENE) | 1.7 | $3.3M | 410k | 8.10 | |
Prothena (PRTA) | 1.6 | $3.0M | 50k | 59.98 | |
Edge Therapeutics | 1.5 | $2.9M | 280k | 10.41 | |
Loxo Oncology | 1.5 | $2.9M | 110k | 26.18 | |
Trillium Therapeutics, Inc. Cmn | 1.4 | $2.6M | 175k | 14.78 | |
Zogenix | 1.3 | $2.5M | 220k | 11.43 | |
Cytomx Therapeutics (CTMX) | 1.3 | $2.5M | 160k | 15.68 | |
Ultragenyx Pharmaceutical (RARE) | 1.3 | $2.5M | 35k | 70.94 | |
Proteostasis Therapeutics In | 1.2 | $2.4M | 152k | 15.59 | |
Lion Biotechnologies | 1.2 | $2.3M | 280k | 8.23 | |
Corium Intl | 1.2 | $2.3M | 400k | 5.63 | |
Amarin Corporation (AMRN) | 1.2 | $2.2M | 700k | 3.19 | |
Neuroderm Ltd F | 0.9 | $1.8M | 99k | 18.49 | |
Nabriva Therapeutics | 0.9 | $1.7M | 240k | 7.05 | |
Innocoll Hldgs | 0.8 | $1.6M | 269k | 5.81 | |
Affimed Therapeutics B V | 0.6 | $1.2M | 430k | 2.78 | |
Intec Pharma | 0.5 | $1.0M | 175k | 5.88 | |
Tenax Therapeutics | 0.5 | $905k | 390k | 2.32 | |
Portola Pharmaceuticals | 0.4 | $795k | 35k | 22.71 | |
Abeona Therapeutics | 0.3 | $600k | 100k | 6.00 | |
AMAG Pharmaceuticals | 0.2 | $368k | 15k | 24.53 | |
Biolinerx Ltd-spons | 0.1 | $288k | 250k | 1.15 | |
DepoMed | 0.0 | $41k | 1.7k | 24.85 |